Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)
Clinical trial NCT06779695 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06779695
- Sponsor
- Korea University Anam Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-21
- Primary completion
- 2028-09-30
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.